array(40) {
  [0]=>
  string(4) "8181"
  ["article_id"]=>
  string(4) "8181"
  [1]=>
  string(42) "Amgen to buy out Japanese partner Astellas"
  ["article_title"]=>
  string(42) "Amgen to buy out Japanese partner Astellas"
  [2]=>
  string(150) "US-based biotech giant Amgen has announced that it will dissolve its joint venture with the Japanese company Astellas in order to operate the unit ind"
  ["short_description"]=>
  string(150) "US-based biotech giant Amgen has announced that it will dissolve its joint venture with the Japanese company Astellas in order to operate the unit ind"
  [3]=>
  string(232) "
US-based biotech giant Amgen has announced that it will dissolve its joint venture with the Japanese company Astellas in order to operate the unit independently. This means Astellas will become a wholly-owned Amgen affiliate.
"
  ["description"]=>
  string(232) "
US-based biotech giant Amgen has announced that it will dissolve its joint venture with the Japanese company Astellas in order to operate the unit independently. This means Astellas will become a wholly-owned Amgen affiliate.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(81) "http://www.gabionline.net//Pharma-News/Amgen-to-buy-out-Japanese-partner-Astellas"
  ["blog_url"]=>
  string(81) "http://www.gabionline.net//Pharma-News/Amgen-to-buy-out-Japanese-partner-Astellas"
  [15]=>
  string(19) "2020-03-06 17:16:29"
  ["add_date"]=>
  string(19) "2020-03-06 17:16:29"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:05"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:05"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8182"
  ["article_id"]=>
  string(4) "8182"
  [1]=>
  string(72) "Delayed entry of buprenorphine generics cost NHS England GBP 0.5 million"
  ["article_title"]=>
  string(72) "Delayed entry of buprenorphine generics cost NHS England GBP 0.5 million"
  [2]=>
  string(150) "A market analysis has shown that lack of competition for generic buprenorphinepatches meant the National Health Service (NHS) in England lost savings."
  ["short_description"]=>
  string(150) "A market analysis has shown that lack of competition for generic buprenorphinepatches meant the National Health Service (NHS) in England lost savings."
  [3]=>
  string(326) "
A market analysis has shown that lack of competition for generic buprenorphinepatches meant the National Health Service (NHS) in England lost savings. The analysis estimates that if all generic drug products entered the market at the same time, the NHS could have saved GBP 0.5 million more over a six-month period [1].
"
  ["description"]=>
  string(326) "
A market analysis has shown that lack of competition for generic buprenorphinepatches meant the National Health Service (NHS) in England lost savings. The analysis estimates that if all generic drug products entered the market at the same time, the NHS could have saved GBP 0.5 million more over a six-month period [1].
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "42"
  ["rss_id"]=>
  string(2) "42"
  [14]=>
  string(117) "http://www.gabionline.net//Generics/Research/Delayed-entry-of-buprenorphine-generics-cost-NHS-England-GBP-0.5-million"
  ["blog_url"]=>
  string(117) "http://www.gabionline.net//Generics/Research/Delayed-entry-of-buprenorphine-generics-cost-NHS-England-GBP-0.5-million"
  [15]=>
  string(19) "2020-03-06 17:15:16"
  ["add_date"]=>
  string(19) "2020-03-06 17:15:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:05"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:05"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8133"
  ["article_id"]=>
  string(4) "8133"
  [1]=>
  string(84) "Vaginal microbiome decoded: Team creates gene database to advance women's health"
  ["article_title"]=>
  string(84) "Vaginal microbiome decoded: Team creates gene database to advance women's health"
  [2]=>
  string(150) "The first reference database that pools metagenomic and metatranscriptomic data from the vaginal microbiome will, according to researchers, aid in und"
  ["short_description"]=>
  string(150) "The first reference database that pools metagenomic and metatranscriptomic data from the vaginal microbiome will, according to researchers, aid in und"
  [3]=>
  string(216) "The first reference database that pools metagenomic and metatranscriptomic data from the vaginal microbiome will, according to researchers, aid in understanding the microorganismsâ role in reproduction and health."
  ["description"]=>
  string(216) "The first reference database that pools metagenomic and metatranscriptomic data from the vaginal microbiome will, according to researchers, aid in understanding the microorganismsâ role in reproduction and health."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(156) "https://www.nutraingredients.com/Article/2020/03/06/Team-creates-gene-database-to-advance-women-s-health?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(156) "https://www.nutraingredients.com/Article/2020/03/06/Team-creates-gene-database-to-advance-women-s-health?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2020-03-06 14:00:00"
  ["add_date"]=>
  string(19) "2020-03-06 14:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:57"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8196"
  ["article_id"]=>
  string(4) "8196"
  [1]=>
  string(75) "addressing feedback from an anonymous survey, coronavirus shaming, and more"
  ["article_title"]=>
  string(75) "addressing feedback from an anonymous survey, coronavirus shaming, and more"
  [2]=>
  string(159) "It’s five answers to five questions. Here we go… 1. Admin’s exceptionally messy desk There is an admin in my department whose desk is atroci"
  ["short_description"]=>
  string(159) "It’s five answers to five questions. Here we go… 1. Admin’s exceptionally messy desk There is an admin in my department whose desk is atroci"
  [3]=>
  string(1594) "
It’s five answers to five questions. Here we go… 1. Admin’s exceptionally messy desk There is an admin in my department whose desk is atrocious. It is covered in not just piles of paper, but trash, food items, and all sorts of miscellaneous junk. This person doesn’t work for me and likely never will, but […]
&#nl
&#nl
You may also like:
&#nl
&#nl
are anonymous surveys really anonymous?
&#nl
my department is making us give each other "group feedback" while standing in a line
&#nl
why does a neat or messy desk reflect on your productivity?
&#nl
&#nl
&#nl
&#nl
addressing feedback from an anonymous survey, coronavirus shaming, and more was originally published by Alison Green on Ask a Manager.
&#nl"
  ["description"]=>
  string(1594) "
It’s five answers to five questions. Here we go… 1. Admin’s exceptionally messy desk There is an admin in my department whose desk is atrocious. It is covered in not just piles of paper, but trash, food items, and all sorts of miscellaneous junk. This person doesn’t work for me and likely never will, but […]
&#nl
&#nl
You may also like:
&#nl
&#nl
are anonymous surveys really anonymous?
&#nl
my department is making us give each other "group feedback" while standing in a line
&#nl
why does a neat or messy desk reflect on your productivity?
&#nl
&#nl
&#nl
&#nl
addressing feedback from an anonymous survey, coronavirus shaming, and more was originally published by Alison Green on Ask a Manager.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "5"
  ["category"]=>
  string(1) "5"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "50"
  ["rss_id"]=>
  string(2) "50"
  [14]=>
  string(114) "https://www.askamanager.org/2020/03/addressing-feedback-from-an-anonymous-survey-coronavirus-shaming-and-more.html"
  ["blog_url"]=>
  string(114) "https://www.askamanager.org/2020/03/addressing-feedback-from-an-anonymous-survey-coronavirus-shaming-and-more.html"
  [15]=>
  string(19) "2020-03-06 13:03:36"
  ["add_date"]=>
  string(19) "2020-03-06 13:03:36"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:24:10"
  ["create_at"]=>
  string(19) "2020-03-11 16:24:10"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8083"
  ["article_id"]=>
  string(4) "8083"
  [1]=>
  string(76) "Silk Road Medical Announces Uplisting to the Nasdaq Global Select Market®"
  ["article_title"]=>
  string(76) "Silk Road Medical Announces Uplisting to the Nasdaq Global Select Market®"
  [2]=>
  string(158) "SUNNYVALE, Calif., March  05, 2020  (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducin"
  ["short_description"]=>
  string(158) "SUNNYVALE, Calif., March  05, 2020  (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducin"
  [3]=>
  string(467) "
SUNNYVALE, Calif., March  05, 2020  (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced today that effective as of market open on March 6, 2020, its common stock has been approved for uplisting to the Nasdaq Global Select Market® and will continue trading under its current ticker symbol "SILK".
"
  ["description"]=>
  string(467) "
SUNNYVALE, Calif., March  05, 2020  (GLOBE NEWSWIRE) -- Silk Road Medical, Inc. (Nasdaq: SILK) (“Silk Road Medical”), a company focused on reducing the risk of stroke and its devastating impact, announced today that effective as of market open on March 6, 2020, its common stock has been approved for uplisting to the Nasdaq Global Select Market® and will continue trading under its current ticker symbol "SILK".
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "27"
  ["rss_id"]=>
  string(2) "27"
  [14]=>
  string(143) "http://www.globenewswire.com/news-release/2020/03/06/1996268/0/en/Silk-Road-Medical-Announces-Uplisting-to-the-Nasdaq-Global-Select-Market.html"
  ["blog_url"]=>
  string(143) "http://www.globenewswire.com/news-release/2020/03/06/1996268/0/en/Silk-Road-Medical-Announces-Uplisting-to-the-Nasdaq-Global-Select-Market.html"
  [15]=>
  string(19) "2020-03-06 11:00:00"
  ["add_date"]=>
  string(19) "2020-03-06 11:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:50"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8105"
  ["article_id"]=>
  string(4) "8105"
  [1]=>
  string(48) "One step closer to understanding the human brain"
  ["article_title"]=>
  string(48) "One step closer to understanding the human brain"
  [2]=>
  string(150) "An international team of scientists has launched a comprehensive overview of all proteins expressed in the brain. The open-access database offers medi"
  ["short_description"]=>
  string(150) "An international team of scientists has launched a comprehensive overview of all proteins expressed in the brain. The open-access database offers medi"
  [3]=>
  string(345) "An international team of scientists has launched a comprehensive overview of all proteins expressed in the brain. The open-access database offers medical researchers an unprecedented resource to deepen their understanding of neurobiology and develop new, more effective therapies and diagnostics targeting psychiatric and neurological diseases. "
  ["description"]=>
  string(345) "An international team of scientists has launched a comprehensive overview of all proteins expressed in the brain. The open-access database offers medical researchers an unprecedented resource to deepen their understanding of neurobiology and develop new, more effective therapies and diagnostics targeting psychiatric and neurological diseases. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200305203537.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200305203537.htm"
  [15]=>
  string(19) "2020-03-06 09:35:37"
  ["add_date"]=>
  string(19) "2020-03-06 09:35:37"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:52"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:52"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8146"
  ["article_id"]=>
  string(4) "8146"
  [1]=>
  string(79) "Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects"
  ["article_title"]=>
  string(79) "Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects"
  [2]=>
  string(155) "A 20-patient Phase 1 study of an RNA drug discovered by Ionis Pharmaceuticals that is being tested as a treatment for Huntington’s disease by Roche "
  ["short_description"]=>
  string(155) "A 20-patient Phase 1 study of an RNA drug discovered by Ionis Pharmaceuticals that is being tested as a treatment for Huntington’s disease by Roche "
  [3]=>
  string(348) "A 20-patient Phase 1 study of an RNA drug discovered by Ionis Pharmaceuticals that is being tested as a treatment for Huntington’s disease by Roche was suspended after two reports of infections related to a device used to take samples of cerebral spinal fluid during the trial. The suspension doesn’t appear to be related to […]"
  ["description"]=>
  string(348) "A 20-patient Phase 1 study of an RNA drug discovered by Ionis Pharmaceuticals that is being tested as a treatment for Huntington’s disease by Roche was suspended after two reports of infections related to a device used to take samples of cerebral spinal fluid during the trial. The suspension doesn’t appear to be related to […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(113) "https://xconomy.com/san-diego/2020/03/05/roche-trial-of-ionis-huntingtons-disease-drug-halted-after-side-effects/"
  ["blog_url"]=>
  string(113) "https://xconomy.com/san-diego/2020/03/05/roche-trial-of-ionis-huntingtons-disease-drug-halted-after-side-effects/"
  [15]=>
  string(19) "2020-03-06 08:40:18"
  ["add_date"]=>
  string(19) "2020-03-06 08:40:18"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:57"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8067"
  ["article_id"]=>
  string(4) "8067"
  [1]=>
  string(49) "Diversicare Announces 2019 Fourth Quarter Results"
  ["article_title"]=>
  string(49) "Diversicare Announces 2019 Fourth Quarter Results"
  [2]=>
  string(150) "BRENTWOOD, Tenn., March  05, 2020  (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (OTCQX: DVCR), a premier provider of long-term care servi"
  ["short_description"]=>
  string(150) "BRENTWOOD, Tenn., March  05, 2020  (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (OTCQX: DVCR), a premier provider of long-term care servi"
  [3]=>
  string(268) "
BRENTWOOD, Tenn., March  05, 2020  (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (OTCQX: DVCR), a premier provider of long-term care services, today announced its results for the fourth quarter ended December 31, 2019.
"
  ["description"]=>
  string(268) "
BRENTWOOD, Tenn., March  05, 2020  (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (OTCQX: DVCR), a premier provider of long-term care services, today announced its results for the fourth quarter ended December 31, 2019.
"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "26"
  ["rss_id"]=>
  string(2) "26"
  [14]=>
  string(120) "http://www.globenewswire.com/news-release/2020/03/05/1996164/0/en/Diversicare-Announces-2019-Fourth-Quarter-Results.html"
  ["blog_url"]=>
  string(120) "http://www.globenewswire.com/news-release/2020/03/05/1996164/0/en/Diversicare-Announces-2019-Fourth-Quarter-Results.html"
  [15]=>
  string(19) "2020-03-06 05:05:00"
  ["add_date"]=>
  string(19) "2020-03-06 05:05:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:41"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8147"
  ["article_id"]=>
  string(4) "8147"
  [1]=>
  string(69) "MacroGenics Chief Medical Officer Jon Wigginton Announces Resignation"
  ["article_title"]=>
  string(69) "MacroGenics Chief Medical Officer Jon Wigginton Announces Resignation"
  [2]=>
  string(150) "MacroGenics (NASDAQ: MGNX) says its chief medical officer, Jon Wigginton, will leave the Rockville, MD-based company as of March 27. The company said "
  ["short_description"]=>
  string(150) "MacroGenics (NASDAQ: MGNX) says its chief medical officer, Jon Wigginton, will leave the Rockville, MD-based company as of March 27. The company said "
  [3]=>
  string(375) "MacroGenics (NASDAQ: MGNX) says its chief medical officer, Jon Wigginton, will leave the Rockville, MD-based company as of March 27. The company said Wigginton, who joined MacroGenics in 2003, plans to resign “to pursue a new opportunity.” As MacroGenics, which is development antibody drugs for cancer, searches for a new CMO, its senior vice president […]"
  ["description"]=>
  string(375) "MacroGenics (NASDAQ: MGNX) says its chief medical officer, Jon Wigginton, will leave the Rockville, MD-based company as of March 27. The company said Wigginton, who joined MacroGenics in 2003, plans to resign “to pursue a new opportunity.” As MacroGenics, which is development antibody drugs for cancer, searches for a new CMO, its senior vice president […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(110) "https://xconomy.com/national/2020/03/05/macrogenics-chief-medical-officer-jon-wigginton-announces-resignation/"
  ["blog_url"]=>
  string(110) "https://xconomy.com/national/2020/03/05/macrogenics-chief-medical-officer-jon-wigginton-announces-resignation/"
  [15]=>
  string(19) "2020-03-06 03:58:29"
  ["add_date"]=>
  string(19) "2020-03-06 03:58:29"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:57"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:57"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8148"
  ["article_id"]=>
  string(4) "8148"
  [1]=>
  string(65) "PsiOxus Therapeutics Appoints Tom Lillie as Chief Medical Officer"
  ["article_title"]=>
  string(65) "PsiOxus Therapeutics Appoints Tom Lillie as Chief Medical Officer"
  [2]=>
  string(150) "Gene therapy developer PsiOxus Therapeutics on Thursday announced it has appointed Tom Lillie as its chief medical officer. Lillie previously held sen"
  ["short_description"]=>
  string(150) "Gene therapy developer PsiOxus Therapeutics on Thursday announced it has appointed Tom Lillie as its chief medical officer. Lillie previously held sen"
  [3]=>
  string(352) "Gene therapy developer PsiOxus Therapeutics on Thursday announced it has appointed Tom Lillie as its chief medical officer. Lillie previously held senior oncology roles at Amgen (NASDAQ: AMGN) and MSD (NYSE: MRK) (as Merck is known outside of the US and Canada). The Oxford, England-based company also said it moved its third gene therapy for […]"
  ["description"]=>
  string(352) "Gene therapy developer PsiOxus Therapeutics on Thursday announced it has appointed Tom Lillie as its chief medical officer. Lillie previously held senior oncology roles at Amgen (NASDAQ: AMGN) and MSD (NYSE: MRK) (as Merck is known outside of the US and Canada). The Oxford, England-based company also said it moved its third gene therapy for […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(104) "https://xconomy.com/europe/2020/03/05/psioxus-therapeutics-appoints-tom-lillie-as-chief-medical-officer/"
  ["blog_url"]=>
  string(104) "https://xconomy.com/europe/2020/03/05/psioxus-therapeutics-appoints-tom-lillie-as-chief-medical-officer/"
  [15]=>
  string(19) "2020-03-06 03:36:33"
  ["add_date"]=>
  string(19) "2020-03-06 03:36:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:58"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:58"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8106"
  ["article_id"]=>
  string(4) "8106"
  [1]=>
  string(67) "Air pollution is one of the world's most dangerous health risks"
  ["article_title"]=>
  string(67) "Air pollution is one of the world's most dangerous health risks"
  [2]=>
  string(138) "Researchers calculate that the effects of air pollution shorten the lives of people around the world by an average of almost three years. "
  ["short_description"]=>
  string(138) "Researchers calculate that the effects of air pollution shorten the lives of people around the world by an average of almost three years. "
  [3]=>
  string(138) "Researchers calculate that the effects of air pollution shorten the lives of people around the world by an average of almost three years. "
  ["description"]=>
  string(138) "Researchers calculate that the effects of air pollution shorten the lives of people around the world by an average of almost three years. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200305135048.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200305135048.htm"
  [15]=>
  string(19) "2020-03-06 02:50:48"
  ["add_date"]=>
  string(19) "2020-03-06 02:50:48"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:52"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:52"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "8107"
  ["article_id"]=>
  string(4) "8107"
  [1]=>
  string(18) "Two-faced bacteria"
  ["article_title"]=>
  string(18) "Two-faced bacteria"
  [2]=>
  string(150) "The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health. Recent studies ha"
  ["short_description"]=>
  string(150) "The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health. Recent studies ha"
  [3]=>
  string(307) "The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health. Recent studies have linked the gut microbiome with several beneficial properties, such as aiding in the development of our immune system and warding off pathogen infections. "
  ["description"]=>
  string(307) "The gut microbiome, which is a collection of numerous beneficial bacteria species, is key to our overall well-being and good health. Recent studies have linked the gut microbiome with several beneficial properties, such as aiding in the development of our immune system and warding off pathogen infections. "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "29"
  ["rss_id"]=>
  string(2) "29"
  [14]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200305135045.htm"
  ["blog_url"]=>
  string(62) "https://www.sciencedaily.com/releases/2020/03/200305135045.htm"
  [15]=>
  string(19) "2020-03-06 02:50:45"
  ["add_date"]=>
  string(19) "2020-03-06 02:50:45"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2020-03-11 16:23:52"
  ["create_at"]=>
  string(19) "2020-03-11 16:23:52"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}